Latest News and Press Releases
Want to stay updated on the latest news?
-
Route 92 Medical announces FDA 510(k) clearance for its FreeClimb 54 reperfusion system, part of its growing portfolio of neurovascular devices.
-
Route 92 Medical announces completion of enrollment in the SUMMIT MAX clinical trial studying their .088" HiPoint Reperfusion Catheter.
-
Route 92 Medical announces the receipt of its 100th patent for its rapidly growing portfolio of neuromuscular intervention products.
-
Route 92 Medical raises over $31 million in oversubscribed Series F equity financing to accelerate its commercialization.
-
Multicenter clinical study results published in Stroke: Vascular and Interventional Neurology show benefits of Route 92 Medical's Tenzing technology.
-
SAN MATEO, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
-
SAN MATEO, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
-
SAN MATEO, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
-
SAN MATEO, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
-
SAN MATEO, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...